Vagus Nerve Stimulation Market: By Product Type, By Application, By End User, and Others), and Region Forecast 2021-2032

download arrow download arrow Download Sample
settings arrow settings arrow email us

Vagus Nerve Stimulation (VNS) Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Implantable VNS Devices and External VNS Devices), By Application (Depression, Epilepsy, and Migraine), By End User (Hospitals, Ambulatory Surgical Centers (ASCS), and Others), and Region Forecast 2021-2032

Report ID:24385

Published Date:Jan 2026

No of Pages:210

Format:

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Vagus Nerve Stimulation Market size was valued at US$ 587.7 million in 2025 and is expected to reach US$ 1,189.7 million by 2032, growing at a significant CAGR of 10.6% from 2026-2032. Vagus nerve stimulation process involves implantation of a device that stimulates the vagus nerve with electrical impulse. The vagus nerves are a pair of nerves that start in the brain and run through the body. These nerves play a major role in receiving messages between the brain and the body.

The vagus nerve stimulation is most often used to treat epilepsy when other treatments havent worked. The devices are designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. Vagus nerve stimulation device is sometimes referred to as a cardiac pacemaker for the brain. The device is placed under the skin on the chest wall and a wire runs from it to the vagus nerve in the neck. The vagus nerve travels through neck and passes between the chest and abdomen and the lower part of the brain. Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve in order to manage and treat various illnesses such as depression and epilepsy. The stimulator is implanted under the skin on the chest, where the wire connects it to the left vagal nerve, in this procedure.

Key Devolpments:

  • In October 2019, LivaNova PLC (NASDAQ:LIVN) (LivaNova or the Company), a market-leading medical technology company, received U.S. Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation Therapy (VNS Therapy) System, which consists of the SenTiv implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy.

summary download arrow Download Sample

Global Vagus Nerve Stimulation Market Summary

Study Period

2026-2032

Base Year

2025

CAGR

10.6%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Vagus Nerve Stimulation (VNS) Market Dynamics

Ascend in commonness of neurological and cardiovascular issue, increment in geriatric populace, development in help from government and private associations, and presentation of positive repayment arrangements drive the market. In any case, surprising expense of these gadgets and complexities related with vagus nerve stimulation devices market limit the market development.

Moreover, high selection rate of negligibly obtrusive VNS methodology and improvement of cutting edge treatments for neurological scatters drive the market development amid the gauge time frame. Nonetheless, mind-boggling expense of gadgets, high support and entanglement identified with vagus nerve stimulation, and stringent administrative endorsements for these gadgets are limiting the development of the global VNS Market.

Global Vagus Nerve Stimulation Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2026-2032

Market CAGR

10.6%

By Type

  • Implantable VNS Devices
  • External VNS Devices

By Indication

  • Depression
  • Epilepsy
  • Migraine

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The vagus nerve stimulation market report provides granular level information about the market size, regional market share, historic market (2021 to 2025) and forecast (2026 to 2032)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global vagus nerve stimulation market size was valued at US$ 587.7 million in 2025 and is expected to reach US$ 1,189.7 million by 2032, growing at a significant CAGR of 10.6% from 2026-2032

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The market key players are Medtronic, Inc., Boston Scientific Corporation, Jude Medical, Inc., Synapse Biomedical, Inc., Neurosigma, Inc., BioControl Medical

Content Updated Date: Feb 2026

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Vagus Nerve Stimulation (VNS) Market Introduction 
2.1.Global Vagus Nerve Stimulation (VNS) Market  - Taxonomy
2.2.Global Vagus Nerve Stimulation (VNS) Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.End user
2.2.4.Region
3.Global Vagus Nerve Stimulation (VNS) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Vagus Nerve Stimulation (VNS) Market Analysis, 2021 - 2025 and Forecast 2026 - 2032
4.1.  Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Vagus Nerve Stimulation (VNS) Market  By Product Type, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
5.1. Implantable VNS
5.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. External VNS
5.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Vagus Nerve Stimulation (VNS) Market  By Application, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
6.1. Depression
6.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Epilepsy
6.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Migraine
6.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Vagus Nerve Stimulation (VNS) Market  By End user, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers (ASCs)
7.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Vagus Nerve Stimulation (VNS) Market  By Region, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Vagus Nerve Stimulation (VNS) Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
9.1. Product Type Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Implantable VNS
9.1.2.External VNS
9.2.  Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Depression
9.2.2.Epilepsy
9.2.3.Migraine
9.3.  End user Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ambulatory Surgical Centers (ASCs)
9.3.3.Others
9.4.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Vagus Nerve Stimulation (VNS) Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Implantable VNS
10.1.2.External VNS
10.2.  Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Depression
10.2.2.Epilepsy
10.2.3.Migraine
10.3.  End user Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ambulatory Surgical Centers (ASCs)
10.3.3.Others
10.4.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Vagus Nerve Stimulation (VNS) Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Implantable VNS
11.1.2.External VNS
11.2.  Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Depression
11.2.2.Epilepsy
11.2.3.Migraine
11.3.  End user Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ambulatory Surgical Centers (ASCs)
11.3.3.Others
11.4.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Vagus Nerve Stimulation (VNS) Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Implantable VNS
12.1.2.External VNS
12.2.  Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Depression
12.2.2.Epilepsy
12.2.3.Migraine
12.3.  End user Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ambulatory Surgical Centers (ASCs)
12.3.3.Others
12.4.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Vagus Nerve Stimulation (VNS) Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Implantable VNS
13.1.2.External VNS
13.2.  Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Depression
13.2.2.Epilepsy
13.2.3.Migraine
13.3.  End user Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ambulatory Surgical Centers (ASCs)
13.3.3.Others
13.4.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.LivaNova PLC (UK)
14.2.2.EnteroMedics Inc. (US)
14.2.3.ElectroCore Medical LLC (US)
14.2.4.Boston Scientific Corporation (US)
14.2.5.Cyberonics, Inc. (US)
14.2.6.NeuroMetrix, Inc.(US)
14.2.7.ImThera Medical (US)
14.2.8.Inspire Medical Systems, Inc.(US)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Medtronic, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Jude Medical, Inc. (U.S.)
  • Synapse Biomedical, Inc. (U.S.)
  • Nevro Corporation (U.S.)
  • Neurosigma, Inc. (U.S.)
  • Neuropace, Inc. (U.S.)
  • Neuronetics, Inc. (U.S.)
  • Cyberonics, Inc. (U.S.)
  • BioControl Medical (Israel)

Related Industry Reports

Implantable Medical Devices Market

Global Portable Pcr Devices Market